1. Food and Drug Administration (FDA). Xarelto drug label [Internet]. [cited 2023 Mar 13]. Available from: 〈https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf〉.
2. Agencia Española del Medicamento y Productos Sanitarios (AEMPS). Xarelto drug label [Internet]. [cited 2023 Mar 13]. Available from: 〈https://cima.aemps.es/cima/dochtml/ft/08472018/FT_08472018.html〉.
3. In Vitro Metabolism of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans;Lang;Drug Metab. Dispos.,2009
4. Therapeutic Drug Monitoring of Direct Oral Anticoagulants May Increase Their Benefit-Risk Ratio;Bernier;J. Cardiovasc Pharm.,2020
5. The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization;Gosselin;J. Thromb. Haemost.,2022